← Leaderboards
Mark S. Warren
Optivia Biotechnology, Inc.
$219,673
Attributed
$439,346
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$439,346 · 1
By mechanism
R43$439,346 · 1
Top collaborators
- Leslie Z Benet1 shared
Most similar at Optivia Biotechnology, Inc.
Same institution · by research overlap
- Dallas Bednarczyk$406,969
Others in their field
Top investigators on “Abcb1 Gene”
- Steven H Liang · Emory University$23,563,221
- Senthilkumar Sadhasivam · Cincinnati Childrens Hosp Med Ctr$12,601,739
- Madhukar H Trivedi · University Of Texas Sw Med Ctr/Dallas$7,780,588
- John A Butera · Hager Biosciences, Llc$6,098,483
- Piero Anversa · New York Medical College$5,646,952
- Beth A McCormick · Univ Of Massachusetts Med Sch Worcester$5,481,615
Research focus
Abcb1 GeneAbsorptionAdverse Drug EffectAffectAnimalsBaseCarrier ProteinsCategoriesCell ModelCellsCentral Nervous System DiseasesClassificationClinical DataDrug Delivery SystemsDrug DevelopmentDrug EfficacyDrug EffluxDrug InteractionsDrug MetabolismDrug Or Chemical Tissue DistributionDrug TransportEnzyme InteractionEnzymes2-Cyclopentyl-5-(5-Isoquinolylsulfonyl)-6-Nitro-1h-Benzo(D)Imidazole